Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Warning: Banning smoking can endanger your political health
Politics

Warning: Banning smoking can endanger your political health

Plenty of Conservative party MPs oppose Rishi Sunak’s anti-tobacco bill.

Bloomberg 28 Apr 2024
Mātai may have invented a 'third wave' in medical imaging
Health

Mātai may have invented a 'third wave' in medical imaging

The institute has impressed a world pioneer in MRI scanning technology.

Greg Hurrell 22 Apr 2024
Cannasouth investors opt for a vote of no confidence
Markets

Cannasouth investors opt for a vote of no confidence

The cannabis firm's future will depend on more capital.

Brent Melville 02 Apr 2024
US hospitals adding billions in 'facility' fees for routine care
Health

US hospitals adding billions in 'facility' fees for routine care

Unsuspecting patients at the mercy of institutions tacking on the bills.